When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Protein C - Wikipedia

    en.wikipedia.org/wiki/Protein_C

    Protein C, also known as autoprothrombin IIA and blood coagulation factor XIV, [5]: 6822 [6] is a zymogen, that is, an inactive enzyme.The activated form plays an important role in regulating anticoagulation, inflammation, and cell death and maintaining the permeability of blood vessel walls in humans and other animals.

  3. Activated protein C resistance - Wikipedia

    en.wikipedia.org/wiki/Activated_protein_C_resistance

    Protein C Anticoagulant Pathway: Thrombin escaping from a site of vascular injury binds to its receptor thrombomodulin (TM) on the intact cell surface. As a result, thrombin loses its procoagulant properties and instead becomes a potent activator of protein C. Activated protein C (APC) functions as a circulating anticoagulant, which ...

  4. Activated protein C resistance test - Wikipedia

    en.wikipedia.org/wiki/Activated_protein_C...

    The activated protein C resistance (APCR) test is a coagulation test used in the evaluation and diagnosis of activated protein C (APC) resistance, a form of hypercoagulability. [ 1 ] [ 2 ] Hereditary APC resistance is usually caused by the factor V Leiden mutation, whereas acquired APC resistance has been linked to antiphospholipid antibodies ...

  5. Drotrecogin alfa - Wikipedia

    en.wikipedia.org/wiki/Drotrecogin_alfa

    Drotrecogin alfa (activated) (Xigris, marketed by Eli Lilly and Company) is a recombinant form of human activated protein C that has anti-thrombotic, anti-inflammatory, and profibrinolytic properties. Drotrecogin alpha (activated) belongs to the class of serine proteases. Drotrecogin alfa has not been found to improve outcomes in people with ...

  6. 3K3A-Activated Protein C - Wikipedia

    en.wikipedia.org/wiki/3K3A-Activated_Protein_C

    3K3A-Activated Protein C (3K3A-APC) is an experimental drug for the treatment of stroke developed by ZZ Biotech. [1] It is also being assessed for the treatment of Alzheimer's disease . [ 2 ] It is the subject of RHAPSODY, a phase II trial to determine safety and tolerability.

  7. Coagulation activation marker - Wikipedia

    en.wikipedia.org/wiki/Coagulation_activation_marker

    Coagulation activation markers are biomarkers of net activation of coagulation and fibrinolysis. [1] [2] Examples include prothrombin fragment 1+2 (F1+2), thrombin–antithrombin complex (TAT), fibrinopeptide A (FpA), fibrin monomers (FMs), plasmin-α 2-antiplasmin complex (PAP), activated protein Cprotein C inhibitor (APC-PCI), and D-dimer (DD).

  8. Activated protein C–protein C inhibitor - Wikipedia

    en.wikipedia.org/wiki/Activated_protein_C...

    Activated protein Cprotein C inhibitor (APC-PCI) is a complex of activated protein C (APC) and protein C inhibitor (PCI). [1] [2] [3] It has been measured in coagulation testing to evaluate coagulation, thrombosis, and other cardiovascular complications. [2] [3] [4] It is a marker of thrombin generation and indicates hypercoagulability.

  9. Endothelial protein C receptor - Wikipedia

    en.wikipedia.org/wiki/Endothelial_protein_C_receptor

    Endothelial protein C receptor (EPCR) also known as activated protein C receptor (APC receptor) is a protein that in humans is encoded by the PROCR gene. [ 5 ] [ 6 ] [ 7 ] PROCR has also recently been designated CD201 ( cluster of differentiation 201).